This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Werthenstein Biopharma Gmbh. Active years: 2007-2023.
Location History:
- South Orange, NJ (US) (2016)
- Maplewood, NJ (US) (2007 - 2023)
Company Filing History:
3 out of 2,405 
1 out of 4,770 
1 out of 2 Years Active: 2007-2023
Title: The Innovative Mind of Clinton Scott Shultz
Introduction
Clinton Scott Shultz, an inventive mind based in Maplewood, NJ, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of three patents to his name, Shultz has focused on developing critical compounds aimed at tackling some of the most challenging medical conditions, including cancer and viral infections.
Latest Patents
Shultz's most recent patents include groundbreaking work on a synthetic pathway to belzutifan and its crystalline phases. This invention provides crystalline forms for particular synthetic intermediates essential for producing belzutifan, a potent HIF-2α inhibitor that shows promise in treating cancer. Additionally, he has developed a patent relating to crystal forms of a Hepatitis C virus (HCV) protease inhibitor, which involves different formulations of a compound designed to inhibit the virus effectively. These contributions reflect Shultz's dedication to advancing pharmaceutical innovations.
Career Highlights
Throughout his career, Clinton Scott Shultz has been associated with renowned companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His work in these organizations has allowed him to delve deep into pharmaceutical research and development, contributing significantly to the industry.
Collaborations
Shultz has collaborated with notable figures in the field, including Gregory L. Beutner and Robert M. Wenslow, Jr. These collaborations have enriched his research endeavors and have led to the conception of innovative solutions in the realm of drug development.
Conclusion
Clinton Scott Shultz stands out as a key figure in the pharmaceutical industry, demonstrating a profound commitment to innovation through his patents. His work continues to pave the way for new treatments and improves the quality of life for those affected by serious health conditions.